MICROBIX BIOSYSTEMS INC (MBX.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:MBX - CA59501P1045 - Common Stock
MBX.CA Key Statistics, Chart & Performance
The current stock price of MBX.CA is 0.24 CAD. In the past year, price decreased by -42.86%.
MBX.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 541.45M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 407.72M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 185.60M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 80.91M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 26.57 | 51.37M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 28.73M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 20.25M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 16.02M | ||
| MPH.CA | MEDICURE INC | N/A | 11.90M | ||
| CSCI.CA | COSCIENS BIOPHARMA INC | N/A | 9.22M | ||
| QPT.CA | QUEST PHARMATECH INC | N/A | 6.77M | ||
| KNE.CA | KANE BIOTECH INC | N/A | 6.69M |
Related stock screener links
About MBX.CA
Company Profile
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The firm develops and commercializes proprietary biological and technology solutions for human health and wellbeing. The company manufactures a range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment and proficiency testing controls (QAPsTM business), and sample collection devices (DxTMTM business). The firm operates in two ways: (i) the development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples, and (ii) the development and commercialization of novel and proprietary products or technologies such as Kinlytic. It's Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots.
Company Info
MICROBIX BIOSYSTEMS INC
265 Watline Avenue
Mississauga ONTARIO L4Z 1P3 CA
CEO: Cameron Groome
Employees: 0
Phone: 19053618910
MICROBIX BIOSYSTEMS INC / MBX.CA FAQ
What does MICROBIX BIOSYSTEMS INC do?
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The firm develops and commercializes proprietary biological and technology solutions for human health and wellbeing. The company manufactures a range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment and proficiency testing controls (QAPsTM business), and sample collection devices (DxTMTM business). The firm operates in two ways: (i) the development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples, and (ii) the development and commercialization of novel and proprietary products or technologies such as Kinlytic. It's Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots.
What is the stock price of MICROBIX BIOSYSTEMS INC today?
The current stock price of MBX.CA is 0.24 CAD.
Does MBX stock pay dividends?
MBX.CA does not pay a dividend.
What is the ChartMill rating of MICROBIX BIOSYSTEMS INC stock?
MBX.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the sector and industry classification for MICROBIX BIOSYSTEMS INC?
MICROBIX BIOSYSTEMS INC (MBX.CA) operates in the Health Care sector and the Biotechnology industry.
What is the market capitalization of MBX stock?
MICROBIX BIOSYSTEMS INC (MBX.CA) has a market capitalization of 33.36M CAD. This makes MBX.CA a Nano Cap stock.
Can you provide the upcoming earnings date for MICROBIX BIOSYSTEMS INC?
MICROBIX BIOSYSTEMS INC (MBX.CA) will report earnings on 2026-02-11.
MBX.CA Technical Analysis
MBX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MBX.CA. The financial health of MBX.CA is average, but there are quite some concerns on its profitability.
MBX.CA Financial Highlights
Over the last trailing twelve months MBX.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -163.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6% | ||
| ROE | -8.08% | ||
| Debt/Equity | 0.24 |
MBX.CA Forecast & Estimates
5 analysts have analysed MBX.CA and the average price target is 0.51 CAD. This implies a price increase of 112.5% is expected in the next year compared to the current price of 0.24.
For the next year, analysts expect an EPS growth of 33.33% and a revenue growth 35.93% for MBX.CA